CHEMUNG FINANCIAL REPORTS 36% GAAP Net Income Decline Due to Strategic Securities Sale; Issues $45M Subordinated Debt
Summary
Chemung Financial reported a 36% GAAP net income drop in 2025 due to a $17.5M loss on strategic securities sales, while adjusted net income grew 17.8%. The company issued $45M in subordinated debt and saw strong loan growth, but also increased credit loss provisions and loan modifications.
Key Events
-
Significant GAAP Net Income Decline
Reported net income for 2025 decreased by 36.2% to $15.1 million ($3.14 EPS) from $23.7 million ($4.96 EPS) in 2024, primarily due to a one-time pre-tax loss on securities sales.
-
Strategic Balance Sheet Repositioning
The company incurred a $17.5 million pre-tax loss from selling $244.8 million of available-for-sale securities to pay off $155.0 million in higher-cost wholesale funding, including brokered deposits and FHLBNY advances.
-
Strong Adjusted Earnings Growth
Excluding the non-recurring securities loss and a branch sale gain, adjusted net income for 2025 increased by 17.8% to $27.9 million ($5.80 EPS), reflecting underlying operational improvements.
-
Subordinated Debt Issuance
In June 2025, Chemung Financial issued $45.0 million in 7.75% fixed-to-floating rate subordinated notes to enhance regulatory capital and support growth initiatives.
Analysis
Chemung Financial Corporation's annual report reveals a significant 36.2% decline in GAAP net income for 2025, primarily driven by a $17.5 million pre-tax loss from the strategic sale of available-for-sale securities. This repositioning aimed to reduce wholesale funding liabilities, including brokered deposits and FHLBNY advances. Despite the GAAP loss, adjusted net income, excluding these non-recurring items, increased by 17.8%. The company also issued $45.0 million in subordinated debt to bolster regulatory capital and support loan growth. While net interest income saw strong growth, the provision for credit losses increased, and loan modifications for financially distressed borrowers more than doubled, indicating some emerging credit quality concerns. Additionally, a valuation allowance of $821 thousand was established against a deferred tax asset related to a capital loss carryforward, reflecting uncertainty about future tax benefit realization. The bank remains well-capitalized, and has $51.0 million available for dividends without prior approval.
At the time of this filing, CHMG was trading at $53.96 on NASDAQ in the Finance sector, with a market capitalization of approximately $258.7M. The 52-week trading range was $40.71 to $65.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.